Granulocyte colony-stimulating factor-induced activation of protein kinase-C in myeloid cells

被引:0
|
作者
Deshpande, RV [1 ]
Peterson, RHF [1 ]
Moore, MAS [1 ]
机构
[1] MEM SLOAN KETTERING CANC CTR, CELL BIOL & GENET PROGRAM, JAMES EWING LAB DEV HEMATOPOIESIS, NEW YORK, NY 10021 USA
关键词
cytokine; signaling; neutrophil; protein kinase C; myeloid; colony-stimulating; receptor;
D O I
10.1002/(SICI)1097-4644(19970901)66:3<286::AID-JCB2>3.0.CO;2-L
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Granulocyte colony stimulating factor (G-CSF) regulates survival, proliferation, differentiation, and activation of myeloid cells. it binds to a high affinity receptor (G-CSF-R) expressed on myeloid cells, for which the signal transduction mechanisms other than protein tyrosine kinase (PTK) activation have not been completely identified. We explored the potential involvement of protein kinase-C (PKC) in G-CSF-R signal transduction. In this report, we provide direct evidence of PKC activation by G-CSF-R. G-CSF treatment of peripheral blood neutrophils, granulocytic cell lines (HL-60, NFS-60, KG-1), and monocytic cell lines (WEHI-3B,U-937) resulted in PKC activation. Chelerythrine chloride and HA-100, an isoquinolinesulfonamide derivative, the specific inhibitors of PKC, 1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid (BAPTA), a chelator of intracellular calcium, and 3,4,5-trimethoxybenzoic acid 8-(diethylamino)-ortyl ester (TMB-8), an inhibitor of intracellular calcium release, blocked G-CSF-induced PKC activation in HL-60 cells, and reduced CD11b upregulation in neutrophils, but did not affect ligand-binding or down-modulation of G-CSF-R. Methyl 2,5-dihydroxycinnamate (MDHC), a potent inhibitor of protein tyrosine kinases (PTK), also inhibited PKC activation in response to G-CSF treatment, suggesting that PKC activation may occur downstream of PTK activation. Our results demonstrate the involvement of PKC in G-CSF-R signal transduction, and suggest a common signaling pathway in myeloid cells of granulocytic and monocytic lineages. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:286 / 296
页数:11
相关论文
共 50 条
  • [21] NEUTROPHIL KINETICS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR-INDUCED NEUTROPENIA IN RATS
    OKADA, Y
    KAWAGISHI, M
    KUSAKA, M
    LIFE SCIENCES, 1990, 47 (15) : PL65 - PL70
  • [22] GRANULOCYTE COLONY-STIMULATING FACTOR
    TABBARA, IA
    SOUTHERN MEDICAL JOURNAL, 1993, 86 (03) : 350 - 355
  • [23] Mechanisms of granulocyte colony-stimulating factor-induced hematopoietic progenitor-cell mobilization
    Link, DC
    SEMINARS IN HEMATOLOGY, 2000, 37 (01) : 25 - 32
  • [24] Granulocyte Colony-Stimulating Factor-Induced Psoriasiform Dermatitis Improved by Narrowband Ultraviolet B
    Jang, Mm Soo
    Park, Jong Bin
    Kim, Joon Hee
    Yang, Myeong Hyeon
    Lee, Kang Hoon
    Han, Sang Hwa
    Suh, Kee Suck
    ANNALS OF DERMATOLOGY, 2017, 29 (02) : 232 - +
  • [25] GRANULOCYTE COLONY-STIMULATING FACTOR
    不详
    CANCER INVESTIGATION, 1989, 7 (05) : 525 - 525
  • [26] Involvement of protein kinase CE in the negative regulation of Akt activation stimulated by granulocyte colony-stimulating factor
    Liu, H
    Qiu, YL
    Xiao, L
    Dong, F
    JOURNAL OF IMMUNOLOGY, 2006, 176 (04): : 2407 - 2413
  • [27] Granulocyte colony-stimulating factor
    Harriss, Julian P.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (09) : 1095 - 1095
  • [28] Granulocyte colony-stimulating factor-induced pulmonary hemorrhage in a healthy stem cell donor
    Kopp, Hans-Georg
    Horger, Marius
    Faul, Christoph
    Hartmann, Jorg T.
    Kanz, Lothar
    Lang, Peter
    Vogel, Wichard
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (21) : 3174 - 3175
  • [29] Suppression of apoptosis and granulocyte colony-stimulating factor-induced differentiation by an oncogenic form of Cbl
    Sinha, S
    Jancarik, J
    Roginskaya, V
    Rothermund, K
    Boxer, LM
    Corey, SJ
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (06) : 746 - 755
  • [30] Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy
    Liongue, Clifford
    Ward, Alister Curtis
    FRONTIERS IN ONCOLOGY, 2014, 4